Pages that link to "Q39487652"
Jump to navigation
Jump to search
The following pages link to Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients (Q39487652):
Displaying 50 items.
- Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum (Q21710731) (← links)
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (Q22241905) (← links)
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (Q22242958) (← links)
- Antibiotics for ventilator-associated pneumonia (Q24240904) (← links)
- Antibiotics for ventilator-associated pneumonia (Q24248832) (← links)
- Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality (Q24530412) (← links)
- Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients (Q24651466) (← links)
- Variation in sepsis care: a wake-up call (Q24795179) (← links)
- Opinion: the clinical use of selective digestive decontamination (Q24795736) (← links)
- Optimizing antibiotic therapy in the intensive care unit setting (Q24796204) (← links)
- Prior antimicrobial therapy in the hospital and other predisposing factors influencing the usage of antibiotics in a pediatric critical care unit (Q24803615) (← links)
- Procalcitonin as a marker of bacterial infection in the emergency department: an observational study (Q24806043) (← links)
- Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit (Q24813204) (← links)
- Whole-genome sequencing targets drug-resistant bacterial infections (Q26799059) (← links)
- The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents (Q26823328) (← links)
- European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid (Q26823518) (← links)
- Advances in the Management of Sepsis and the Understanding of Key Immunologic Defects (Q26865386) (← links)
- Treatment of Gram-positive infections in critically ill patients (Q27015976) (← links)
- Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans (Q27339671) (← links)
- Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia (Q28071882) (← links)
- Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity? (Q28080078) (← links)
- Efficacy and safety of biapenem in treatment of infectious disease: a meta-analysis of randomized controlled trials (Q28251775) (← links)
- Does it Matter if we get it right? Impact of appropriateness of empiric antimicrobial therapy among surgical patients (Q28392467) (← links)
- Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study (Q28534034) (← links)
- Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study (Q28551453) (← links)
- Automated extraction improves multiplex molecular detection of infection in septic patients (Q28748877) (← links)
- Emergency medicine pharmacists and sepsis management (Q30223813) (← links)
- The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. (Q30238578) (← links)
- Impact of bloodstream infection on outcomes among infected surgical inpatients. (Q30307242) (← links)
- All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. (Q30332721) (← links)
- Characteristics of surgical patients receiving inappropriate empiric antimicrobial therapy. (Q30361739) (← links)
- Ventilator-Associated Pneumonia in Patients with 2009 Pandemic Influenza A (H1N1) Infection: An Observational Study (Q30399459) (← links)
- Antibiotic stewardship in the intensive care unit (Q30408712) (← links)
- Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study (Q30416983) (← links)
- Accuracy of LightCycler(R) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol (Q30485275) (← links)
- Enhanced nucleic acid amplification with blood in situ by wire-guided droplet manipulation (WDM). (Q30560163) (← links)
- Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)? (Q30684615) (← links)
- Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials (Q30756968) (← links)
- Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002. (Q30939930) (← links)
- Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients? (Q31113551) (← links)
- Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study (Q31918107) (← links)
- Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia (Q32100719) (← links)
- Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures (Q33202720) (← links)
- Staphylococcus aureus: role and impact in the treatment of nosocomial pneumonia (Q33227419) (← links)
- Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study (Q33369556) (← links)
- Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time (Q33373058) (← links)
- Correlation of American Burn Association sepsis criteria with the presence of bacteremia in burned patients admitted to the intensive care unit (Q33398989) (← links)
- Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted Mortality (Q33425748) (← links)
- Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients. (Q33559047) (← links)
- Effect of antifungal therapy timing on mortality in cancer patients with candidemia (Q33559164) (← links)